Clearmind Medicine Inc.CMNDNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank78
Year-over-Year Change
Year-over-year book value per share growth
Latest
5.26%
↑ 37% vs avg
Percentile
P78
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
3.84%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 5.26% |
| Q3 2025 | -56.47% |
| Q2 2025 | -32.61% |
| Q1 2025 | -7.61% |
| Q4 2024 | -25.11% |
| Q3 2024 | -30.60% |
| Q2 2024 | -56.30% |
| Q1 2024 | 61.54% |
| Q4 2023 | -69.38% |
| Q3 2023 | -53.92% |
| Q2 2023 | -60.91% |
| Q1 2023 | 371.17% |
| Q4 2022 | -389.91% |
| Q3 2022 | -80.33% |
| Q2 2022 | -43.74% |
| Q1 2022 | -38.02% |
| Q4 2021 | -37.68% |
| Q3 2021 | 102.62% |
| Q2 2021 | 401.68% |
| Q1 2021 | -16.36% |
| Q4 2020 | -41.33% |
| Q3 2020 | 10.59% |
| Q2 2020 | 304.64% |
| Q1 2020 | -18.90% |
| Q4 2019 | -15.85% |
| Q3 2019 | -9.95% |
| Q2 2019 | -18.72% |
| Q1 2019 | -9.46% |
| Q4 2018 | 27.19% |
| Q3 2018 | -21.06% |
| Q2 2018 | -23.79% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |